| | |
| Clinical data | |
|---|---|
| Other names |
|
| Routes of administration | By mouth |
| Drug class | Androgen; anabolic steroid; progestogen |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C18H25O2 |
| Molar mass | 273.396 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
19-Nordehydroepiandrosterone (19-nor-DHEA), or 19-nor-5-dehydroepiandrosterone (19-nor-5-DHEA), is an estrane (19-norandrostane) steroid which was never marketed. [1] [2] It is the combined derivative of the androgen/anabolic steroid nandrolone (19-nortestosterone) and the androgen prohormone dehydroepiandrosterone (DHEA, or more specifically 5-DHEA). [1] [2] Related compounds include 19-nor-5-androstenediol, bolandiol (19-nor-4-androstenediol), and bolandione (nor-4-androstenedione), which are all known orally active prohormones of nandrolone. [2] [3] [4] 19-Nor-DHEA may occur as a metabolite of bolandione and related steroids. [2]
| ER Tooltip Estrogen receptor |
| ||||||
|---|---|---|---|---|---|---|---|
| GPER Tooltip G protein-coupled estrogen receptor |
| ||||||
| PR Tooltip Progesterone receptor |
| ||||||
|---|---|---|---|---|---|---|---|
| mPR Tooltip Membrane progesterone receptor (PAQR Tooltip Progestin and adipoQ receptor) |
| ||||||
| | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |